Grantham, Mayo, Van Otterloo & Co (GMO)
AMRX icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Amneal Pharmaceuticals AMRX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,100
Closed -$71.6K – 579
2023
Q2 		$71.6K Hold
23,100
– – ﹤0.01% 664
2023
Q1 		$32.1K Buy
+23,100
New +$46K ﹤0.01% 690
2022
Q3 		– Sell
-146,500
Closed -$466K – 713
2022
Q2 		$466K Hold
146,500
– – ﹤0.01% 621
2022
Q1 		$611K Buy
146,500
+122,100
+500% +$541K ﹤0.01% 579
2021
Q4 		$117K Buy
+24,400
New +$122K ﹤0.01% 672
2021
Q1 		– Sell
-154,700
Closed -$707K – 836
2020
Q4 		$707K Sell
154,700
-63,400
-29% -$281K ﹤0.01% 629
2020
Q3 		$846K Buy
+218,100
New +$933K 0.01% 547

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return